Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3739 3773 3794
This examiner grants 85% of resolved cases
Amanda L. Zink is an examiner in Tech Center 3700, specifically assigned to Art Unit 3739. She has a history of 681 resolved cases, which provides a reliable basis for analysis. The allowance rate for this examiner is 85.2%, which is high and suggests a favorable outlook for applicants. This rate across 681 resolved cases indicates a consistent pattern of granting patents within this technical field.
The median days to allowance for successful applications is 1212. This timeline shows the duration the process typically takes to complete. Interestingly, the interview lift of 3.1% is relatively low. This 3.1% lift suggests that interviews may not be as impactful here as they are with other examiners, likely because the base allowance rate of 85.2% is already high. Practitioners should plan for a 1212-day median timeline while recognizing that the high allowance rate provides a strong foundation for success. The 3.1% interview lift and Art Unit 3739 are defining factors in this profile.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18844457 | SURGICAL SMOKE FILTERING DEVICE | Non-Final OA | Covidien LP |
| 18507558 | MEDICAL INSTRUMENT WITH MECHANICAL INTERLOCK | Non-Final OA | Auris Health, Inc. |
| 18351120 | Cryoablation Devices And Related Methods | Non-Final OA | Regents of the University of California |
| 17971762 | POSITION TRACKING FOR PULSED FIELD ABLATION | Final Rejection | BIOSENSE WEBSTER (ISRAEL) LTD. |
| 18512161 | PULSED FIELD ABLATION DEVICE AND METHOD | Non-Final OA | BTL Medical Development a. s. |
| 18374601 | Treatment of Kidney Disease Using Renal Nerve Denervation Via the Renal Pelvis | Non-Final OA | Verve Medical, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy